Rabeprazole-d4

• CAT Number: R044569
• CAS Number: 934295-48-4
• Molecular Formula: C18H21N3O3S
• Molecular Weight: 363.468
• Purity: ≥95%
• Synonyms: 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-4,5,6,7-d4; (±)-Rabeprazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d4; 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]
• Target: Apoptosis
• Storage: Store at RT
• IUPAC Name: 4,5,6,7-tetradeuterio-2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole
• InChI: InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)/i3D,4D,6D,7D
• InChIKey: YREYEVIYCVEVJK-ZDPIWEEJSA-N
• SMILES: [2H]C1=C(C(=C2C(=C1[2H])NC(=N2)S(=O)CC3=NC=CC(=C3C)OCCCOC)[2H])[2H]

Rabeprazole-d4 is a deuterated form of rabeprazole, featuring four deuterium atoms incorporated into its molecular structure. This high-purity isotopically labeled compound is essential for research in gastroenterology, pharmacology, and drug metabolism. Rabeprazole-d4 is particularly valuable for studying the metabolic pathways, pharmacokinetics, and therapeutic efficacy of rabeprazole, a proton pump inhibitor (PPI) used to treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers. The deuterium labeling allows for precise tracking and quantification in biological systems using mass spectrometry, enhancing the accuracy of studies on drug absorption, distribution, metabolism, and excretion. This compound is a critical tool for researchers focused on optimizing PPI therapies, understanding the safety and efficacy of rabeprazole, and exploring its mechanisms of action in various gastrointestinal disorders, providing consistent and reliable results in various experimental applications.